Market Trends of Moist Wound Dressings Industry
The Diabetic Ulcers Segment is Expected to Hold the Largest Share Over the Forecast Period
A diabetic foot ulcer is an open wound or sore commonly occurring in diabetic patients located on the bottom of the foot. Despite foot ulcers, a frequent complication of poorly managed diabetes often occurs despite dietary changes, exercise, and insulin therapy. Hydrocolloid and hydrogel dressings are the primary moist wound dressings used to treat these ulcers.
Rising diabetes rates and the complications of diabetic foot ulcers are key factors driving the segment's growth. For instance, according to the study published in Scientific Reports in January 2024, the annual incidence of diabetic foot ulcers varied from 1.9 to 26.1 million worldwide in 2022. According to the NCBI study published in August 2022, between 9.1 and 26.1 million people develop diabetic foot ulcers each year. A significant number of individuals with diabetes mellitus, estimated at 15% to 25%, experience a diabetic foot ulcer at some point in their lives. The rising prevalence of diabetes is directly contributing to the increasing incidence of diabetic foot ulcers. Consequently, the growing number of diabetes and diabetic foot ulcer cases is expected to drive the market’s growth over the forecast period.
Market players are introducing moist wound dressings to treat diabetic ulcers; this is expected to drive segmental growth. For instance, in March 2023, Bactiguard introduced biocompatible and effective wound care products in the United Kingdom and Ireland for the management of difficult-to-treat wounds such as diabetic foot ulcers. Additionally, in October 2022, Healthium Medtech introduced innovative dressing Theruptor Novo in various countries such as the United States, India, and Canada. Theruptor Novo has anti-microbial and non-toxic properties to manage diabetic foot ulcers caused by complications such as diabetic neuropathy. Thus, the introduction of innovative wound dressings to treat diabetic foot ulcers is expected to contribute to the segment’s growth.
North America is Expected to Hold a Significant Share of the Market Over the Forecast Period
North America is expected to hold a significant share of the moist wound dressings market throughout the forecast period. Various factors contribute to the market's growth in the region, such as the growing burden of inflation and the presence of key market players.
The rise in the prevalence of diabetes, burns, and surgeries led to an increase in surgical site infection (SSI) cases in the region. For instance, according to the study published in February 2024, the prevalence of SSI after knee surgery in the United States was 2% in 2023. Moist wound dressings are widely used in cases of surgical site infection. Thus, increasing cases of surgical site infection are expected to propel the demand for moist wound dressing, thereby driving the market’s growth in the region over the forecast period.
Key product launches, high concentration of market players or manufacturer's presence, acquisitions and partnerships among significant players, and increasing cases of chronic diseases, burns, accidents, and chronic and acute wounds in the United States are some of the factors driving the growth of the moist wound dressings market. An article published in the Journal of Advances in Wound Care in October 2023 mentioned that chronic wounds significantly impair the quality of life (QoL) for approximately 2.5% of the United States population. Thus, driven by the rising prevalence of accidents and chronic wounds in the United States, the market for wound care is anticipated to witness robust growth during the forecast period.
Additionally, market player initiatives such as product launches are expected to drive market growth in the region. For instance, in November 2023, Kane Biotech Inc. collaborated with ProgenaCare Global LLP to introduce a rebranded Revyve anti-microbial wound gel. This wound gel is incorporated with coactiv+ technology and polyhexamethylene biguanide (PHMB), coupled with a non-ionic pluronic surfactant with thermo-gelling characteristics. It provides a moist environment for chronic wounds and promotes healing. In January 2023, Convatec introduced innovative dressings Convafoam in the United States. This dressing can be used to manage wounds and provide protection to the skin. Thus, such innovative products are expected to be adopted by the patient pool and are likely to boost the market growth in the region.
Therefore, factors such as the increasing burden of infections and key product launches are expected to contribute to the market’s growth in the region.
